Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Frequency Therapeutics Stock (NASDAQ: FREQ) stock price, news, charts, stock research, profile.
Open0.390 | Close0.370 |
Vol / Avg.108.136K / 1.688M | Mkt Cap13.370M |
Day Range0.370 - 0.410 | 52 Wk Range0.326 - 5.590 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.300 | 0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-26 | Baird | Jack Allen | Downgrades | OutperformNeutral | Lowers | 4.00 | 0.50 |
2023-02-15 | Chardan Capital | Daniil Gataulin | Downgrades | BuyNeutral | - | - | - |
2023-02-14 | Oppenheimer | Jay Olson | Downgrades | OutperformPerform | - | - | - |
2023-02-14 | Baird | Jack Allen | Maintains | Outperform | Lowers | 10.00 | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FREQ | Frequency Therapeutics | -1.29% | 13.4M |
ERNA | Eterna Therapeutics | -4.42% | 11.7M |
IMRN | Immuron | 8.85% | 11.9M |
IMPL | Impel Pharmaceuticals | -2.16% | 10.2M |
DOMH | Dominari Holdings | -1.68% | 12.3M |
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Nanoviricides (AMEX:NNVC).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Baird on Tuesday, September 26, 2023. The analyst firm set a price target for 0.50 expecting FREQ to rise to within 12 months (a possible 36.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $0.3661 last updated September 28, 2023 at 11:10 AM UTC.
There is no dividend information for Frequency Therapeutics.
Frequency Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.